2000;101:2557 67. 165. Abu-Assi E, Ferreira-Gonzalez I, Ribera A, et al. Do GRACE (Global Registry of Acute Coronary events) risk scores still maintain their perfor- mance for predicting mortality in the era of contemporary management of acute coronary syndromes? . Am Heart J. 2010;160:826 34. 166. Eagle KA, Lim MJ, Dabbous OH, et al. A validated prediction mod- el for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA. 2004;291:2727 33. 167. Go J, Narmi A, Sype J, et al. Impact of renal dysfunction on the prognos- tic value of the TIMI risk score in patients with non-ST elevation acute coronary syndrome. Coron Artery Dis. 2011;22:411 15. 168. Huynh T, Nasmith J, Luong TM, et al. Complementary prognostic val- ues of ST segment deviation and Thrombolysis In Myocardial Infarction (TIMI) risk score in non-ST elevation acute coronary syndromes: Insights from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) study. Can J Cardiol. 2009;25:e417 21. 169. Meune C, Drexler B, Haaf P, et al. The GRACE score's performance in predicting in-hospital and 1-year outcome in the era of high-sensi- tivity cardiac troponin assays and B-type natriuretic peptide. Heart. 2011;97:1479 83. 170. Pollack CV Jr, Sites FD, Shofer FS, et al. Application of the TIMI risk score for unstable angina and non-ST elevation acute coronary syndrome to an unselected emergency department chest pain population. Acad Emerg Med. 2006;13:13 18. 171. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344:1879 87. 172. Dolor RJ, Melloni C, Chatterjee R, et al. Treatment strategies for women with coronary artery disease. 